NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

What exactly would these partners be getting. I'm certainly no expert, but I believe that once DCVax-L is approved it can be used with other approved products as Oncologists and patients agree to do. Putting it in combination trials with certain therapeutics may result in label changes that add to treatment protocols, but I don't know that Drs. choosing other competitive products can be prevented if that's their choice.

I believe a partnership with a BP will bring in billions, that's the kind of money that's needed to do multiple trials and handle getting our vaccine into countries all over the world. I would rather see that sort of money come from a partnership than massive dilution. A partner will probably pay a premium that's roughly double the current share price, and essentially move the share price to that level. Dilutive funding is normally done at a discount to the current share price and does little to elevate the share price. I'm not looking for either until our share price is dramatically higher, but I think we'd be well served by a BP partner that took our share price well into double digits once we got the share price well into single digits, or higher.

Gary